About 8 results found for searched term "KLF" (0.134 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M49637 | CKLF1-C27 | CCR |
| CKLF1-C27, a C-terminal peptide of CKLF1, binds to CCR4 receptor and activates ERK1/2 pathway. | ||
| M49638 | CKLF1-C27 TFA | CCR |
| CKLF1-C27, a C-terminal peptide of CKLF1, binds to CCR4 receptor and activates ERK1/2 pathway. | ||
| M53871 | CKLF1-C19 | CCR |
| CKLF1-C19 is the C-terminal peptide of human chemokine-like factor 1 (CKLF1). | ||
| M6601 | CID 5951923 | Others |
| CID 5951923 is a krüppel-like factor 5 (KLF5) inhibitor. | ||
| M8650 | ML264 | KLF |
| CID-51003603 | ||
| ML264 is a potent and selective inhibitor of Kruppel-like factor 5 (KLF5) expression. | ||
| M15105 | SR15006 | Others |
| SR15006 is an inhibitor of Kruppel-like factor 5 (KLF5) (IC50 = 41.6 nM in DLD-1 CRC cells). | ||
| M20704 | SR18662 | Others |
| SR18662 is an optimized compund based on ML264 that inhibits Krüppel-like factor 5 (KLF5) with IC50 of 4.4 nM. SR18662 reduces the viability of multiple colorectal cancer cell lines. SR18662 induces apoptosis. | ||
| M29680 | SR18662 | KLF |
| SR18662 is a potent inhibitor of Krüppel-like factor five (KLF5) with an IC50 of 4.4 nM and an analogue of ML264 with improved inhibitory potency against colorectal cancer cells. SR18662 can be used for the study of colorectal cancer. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
